Cheng Qiu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms
Papers in
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 5
-
- Cancer-related molecular mechanisms research 14
- MicroRNA in disease regulation 4
- Co-authors
- Zhi Min Yang (3 shared papers)Si Qi Huang (2 shared papers)Jie Peng (1 shared paper)Pieter Bas Kwak (1 shared paper)Ruize Qu (10 shared papers)Yunpeng Zhao (8 shared papers)Wenhan Wang (9 shared papers)Dan Luo (5 shared papers)
- Journals
- International Immunopharmacology (3 papers)Frontiers in Oncology (3 papers)The FASEB Journal (2 papers)International Journal of Medical Sciences (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Cheng Qiu
62 papers receiving 1.2k citations
Cheng Qiu's Hit Papers
Peers
Comparison fields: 5 of 93
- Cancer Research 316
- Rheumatology 134
- Plant Science 313
- Molecular Biology 499
- Pulmonary and Respiratory Medicine 176
Countries citing papers authored by Cheng Qiu
This map shows the geographic impact of Cheng Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Qiu more than expected).
Fields of papers citing papers by Cheng Qiu
This network shows the impact of papers produced by Cheng Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Qiu. The network helps show where Cheng Qiu may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheng Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 118 | |
| 2 | 2007 | 115 | |
| 3 | 2009 | 113 | |
| 4 | 2020 | 71 | |
| 5 | Piezo1 channel exaggerates ferroptosis of nucleus pulposus cells by mediating mechanical stress-induced iron influx Hit paper breakdown → | 2024 | 61 |
| 6 | 2019 | 59 | |
| 7 | 2021 | 57 | |
| 8 | 2017 | 56 | |
| 9 | 2019 | 39 | |
| 10 | 2020 | 31 | |
| 11 | 2018 | 30 | |
| 12 | 2018 | 30 | |
| 13 | 2016 | 29 | |
| 14 | 2022 | 26 | |
| 15 | The association of HOTAIR expression with clinicopathological features and prognosis in gastric cancer patients. | 2016 | 26 |
| 16 | 2019 | 24 | |
| 17 | 2018 | 20 | |
| 18 | 2016 | 18 | |
| 19 | 2022 | 16 | |
| 20 | Long noncoding RNA ANRIL: a potential novel prognostic marker in cancer: a meta-analysis. | 2016 | 16 |
About Cheng Qiu
Cheng Qiu is a scholar working on Molecular Biology, Cancer Research, Rheumatology, Pulmonary and Respiratory Medicine and Immunology, having authored 67 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (14 papers), Ferroptosis and cancer prognosis (8 papers), Osteoarthritis Treatment and Mechanisms (6 papers), Circular RNAs in diseases (5 papers), RNA modifications and cancer (5 papers), Biomarkers in Disease Mechanisms (4 papers), Plant Molecular Biology Research (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (316 citations), Rheumatology (134 citations), Plant Science (313 citations), Molecular Biology (499 citations) and Pulmonary and Respiratory Medicine (176 citations). Cheng Qiu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Zhi Min Yang, Si Qi Huang, Jie Peng, Pieter Bas Kwak, Ruize Qu, Yunpeng Zhao, Wenhan Wang, Dan Luo, Kai Guo and Yiyong Zhu. Their work appears in journals such as International Immunopharmacology, Frontiers in Oncology, The FASEB Journal, International Journal of Medical Sciences and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.